| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Physiology, School of Medicine, Southern Illinois University, Carbondale, Illinois 62901–6512;
Instituto de Quimica y Fisicoquimica Biologicas (UBA-CONICET), 1113 Buenos Aires, Argentina;
Department of Animal Science, Food and Nutrition, Southern Illinois University, Carbondale, Illinois 62901–4417;
¶ Edison Biotechnology Institute and Department of Clinical Research, Ohio University College of Osteopathic Medicine, Ohio University, Athens, Ohio 45701
Transgenic mice overexpressing growth hormone (GH) exhibit alterations in the function of the hypothalamic-pituitary-gonadal (HPG) axis and the H-P-adrenal axis. Alterations in the turnover of hypothalamic neurotransmitters, in plasma hormone levels, and in regulation of their release are associated with reproductive deficits, particularly in females. Results reported after publication of our minireview on this subject provided evidence that GH-transgenic mice have increased binding of GH to GH binding proteins in plasma, are hyperinsulinemic and insulin resistant, and have major alterations in energy budgets with increased allocation to growth. Reduced life span and fertility of these animals may be related to insufficient allocation of energy to reproduction and maintenance. Growth hormone resistance induced by transgenic expression of an antagonistic bGH analog or by targeted disruption (knock-out, KO) of the GH receptor (GH-R) gene leads to dramatic suppression of plasma levels of insulin-like growth factor-1 (IGF-1), and dwarf phenotype due to reduced growth and increased adiposity. In both models of GH resistance, there are marked reproductive deficits in females, decline of breeding performance of males, and alterations in the function of the HPG axis. In GH-R-KO females, puberty is delayed, and litter size is reduced. Fetal weights are reduced whereas placental weights are increased, and the weight of newborn pups is reduced despite an increase in the length of gestation. In GH-R-KO males, copulatory behavior and fertility are reduced, plasma PRL is elevated, and responses to lutenizing hormone releasing hormone (LHRH) in vivo and to LH in vitro are suppressed. However, reproductive deficits in GH-R-KO mice are very mild when compared to those described previously in IGF-KO animals. Apparently, the amounts of IGF-1 that may be produced locally in the absence of GH stimulation are sufficient for sexual maturation and fertility in both sexes, whereas quantitative deficits in reproductive function reflect absence of GH-dependent IGF-1 production and other consequences of eliminating GH signaling. The reproduction phenotype of the GH-R-KO mice is also mild when compared to dwarf mice that lack GH, prolactin (PRL), and thyroid stimulating hormone (TSH). This is presumably related to the presence of redundant mechanisms in the stimulatory control of the gonads by the pituitary and the ability of animals capable of producing PRL and TSH to compensate partially for the absence of GH signaling.
This article has been cited by other articles:
|
|
 |
|
  F. Bogazzi, F. Raggi, F. Ultimieri, D. Russo, A. D'Alessio, A. Manariti, S. Brogioni, L. Manetti, and E. Martino Regulation of cardiac fatty acids metabolism in transgenic mice overexpressing bovine GH J. Endocrinol., June 1, 2009; 201(3): 419 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jin, N. J. Lanning, and C. Carter-Su JAK2, But Not Src Family Kinases, Is Required for STAT, ERK, and Akt Signaling in Response to Growth Hormone in Preadipocytes and Hepatoma Cells Mol. Endocrinol., August 1, 2008; 22(8): 1825 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nakahara, M. Nakagawa, Y. Baba, M. Sato, K. Toshinai, Y. Date, M. Nakazato, M. Kojima, M. Miyazato, H. Kaiya, et al. Maternal Ghrelin Plays an Important Role in Rat Fetal Development during Pregnancy Endocrinology, March 1, 2006; 147(3): 1333 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J G Miquet, A I Sotelo, F P Dominici, M S Bonkowski, A Bartke, and D Turyn Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance J. Endocrinol., December 1, 2005; 187(3): 387 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. D. Sharp and A. Bartke Evidence for Down-Regulation of Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR)-Dependent Translation Regulatory Signaling Pathways in Ames Dwarf Mice J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2005; 60(3): 293 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Van Vugt, H. J.M. Swarts, B. J.M. Van de Heijning, and E. M. Van der Beek Centrally Applied Somatostatin Inhibits the Estrogen-Induced Luteinizing Hormone Surge via Hypothalamic Gonadotropin-Releasing Hormone Cell Activation in Female Rats Biol Reprod, September 1, 2004; 71(3): 813 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Chandrashekar, D. Zaczek, and A. Bartke The Consequences of Altered Somatotropic System on Reproduction Biol Reprod, July 1, 2004; 71(1): 17 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Kramer, W. J. Cook, F. P. Roth, J. Zhu, H. Holman, D. M. Knipe, and D. M. Coen Latent Herpes Simplex Virus Infection of Sensory Neurons Alters Neuronal Gene Expression J. Virol., September 1, 2003; 77(17): 9533 - 9541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ajo, L. Cacicedo, C. Navarro, and F. Sanchez-Franco Growth Hormone Action on Proliferation and Differentiation of Cerebral Cortical Cells from Fetal Rat Endocrinology, March 1, 2003; 144(3): 1086 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Keene, M. O. Suescun, M. G. Bostwick, V. Chandrashekar, A. Bartke, and J. J. Kopchick Puberty Is Delayed in Male Growth Hormone Receptor Gene--Disrupted Mice J Androl, September 1, 2002; 23(5): 661 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. D. Turner, J. R. Knapp, F. M. Byers, and J. J. Kopchick Physical and Mechanical Characteristics of Tibias from Transgenic Mice Expressing Mutant Bovine Growth Hormone Genes Experimental Biology and Medicine, February 1, 2001; 226(2): 133 - 139. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
